{"id":"https://openalex.org/W4286295308","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16015","title":"Anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.","display_name":"Anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4286295308","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16015"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.e16015","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16015","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16015","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100367493","display_name":"Yanfeng Zhang","orcid":"https://orcid.org/0000-0002-3859-3839","observed_orcids":["https://orcid.org/0000-0002-3859-3839","https://orcid.org/0000-0001-7197-1128"]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan-Feng Zhang","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060794030","display_name":"Anlin Hao","orcid":"https://orcid.org/0000-0001-7450-6467","observed_orcids":["https://orcid.org/0000-0001-7450-6467"]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"An-Lin Hao","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113930341","display_name":"Yonggui Hong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yong-Gui Hong","raw_affiliation_strings":["Department of Oncology, Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100452150","display_name":"Xiaoming Li","orcid":"https://orcid.org/0000-0003-3899-7021","observed_orcids":["https://orcid.org/0000-0003-3899-7021","https://orcid.org/0000-0003-3467-7100"]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiao-Ming Li","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056810152","display_name":"Wei-Min Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei-Min Liang","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015314077","display_name":"Zhi-Xin Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhi-Xin Zheng","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065444744","display_name":"Guangyi Yang","orcid":"https://orcid.org/0009-0009-9832-1243","observed_orcids":["https://orcid.org/0009-0009-9832-1243"]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Guang-Yi Yang","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101820860","display_name":"Xiaofeng Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiao-Feng Guo","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046733292","display_name":"Yan-Yan Wen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan-Yan Wen","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109613963","display_name":"Heng Cao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Heng Cao","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028233966","display_name":"Cheng Le","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Cheng Le","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hua-Jie Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hua-Jie Song","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064783733","display_name":"Wenzhong Su","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163319","display_name":"Anyang Tumor Hospital","ror":"https://ror.org/01hs21r74","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210163319"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wen-Zhong Su","raw_affiliation_strings":["Anyang Tumor Hospital, Anyang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anyang Tumor Hospital, Anyang, China;","institution_ids":["https://openalex.org/I4210163319"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210163319"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"e16015","last_page":"e16015"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10619","display_name":"Esophageal Cancer Research and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/esophageal-squamous-cell-carcinoma","display_name":"esophageal squamous cell carcinoma","score":0.9240000247955322},{"id":"https://openalex.org/keywords/anlotinib","display_name":"anlotinib","score":0.9160000085830688},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5889999866485596},{"id":"https://openalex.org/keywords/locally-advanced-esophageal-cancer","display_name":"locally advanced esophageal cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/radical-esophagectomy","display_name":"radical esophagectomy","score":0.699999988079071},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.5149999856948853},{"id":"https://openalex.org/keywords/r0-resection","display_name":"R0 resection","score":0.6930000185966492},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.6800000071525574},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7620000243186951},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6019999980926514},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.6840000152587891},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.3240000009536743},{"id":"https://openalex.org/keywords/postoperative-complications","display_name":"postoperative complications","score":0.37299999594688416}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9558364152908325},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.7317274212837219},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6649488210678101},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6406944394111633},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5850442051887512},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5328730940818787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4965820908546448},{"id":"https://openalex.org/C2994415158","wikidata":"https://www.wikidata.org/wiki/Q372701","display_name":"Esophageal squamous cell carcinoma","level":3,"score":0.48288702964782715},{"id":"https://openalex.org/C2779742542","wikidata":"https://www.wikidata.org/wiki/Q372701","display_name":"Esophageal cancer","level":3,"score":0.45257773995399475},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4453062117099762},{"id":"https://openalex.org/C2910430875","wikidata":"https://www.wikidata.org/wiki/Q7251413","display_name":"Nab-paclitaxel","level":4,"score":0.428785502910614},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4236736297607422},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4064408838748932},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.37774956226348877},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36825814843177795},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.14156964421272278},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.e16015","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16015","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.e16015","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4318904243","https://openalex.org/W4295828352","https://openalex.org/W4317862732","https://openalex.org/W3169705743","https://openalex.org/W3122238540","https://openalex.org/W4406869940","https://openalex.org/W4400264740","https://openalex.org/W4379333615","https://openalex.org/W4401325326","https://openalex.org/W3088667304"],"abstract_inverted_index":{"e16015":[0],"Background:":[1],"Neoadjuvant":[2],"therapy":[3,40,51],"could":[4],"significantly":[5],"improve":[6],"survival":[7],"for":[8,33,77,120],"patients":[9,81,89,101,135,201,207,218,225,231,279,288,372],"with":[10,72,82,109,314,349],"locally":[11],"advanced":[12],"esophageal":[13],"cancer.":[14],"However,":[15],"postoperative":[16],"complications":[17],"and":[18,37,65,69,87,114,161,187,223,257,267,332,351,361],"recurrence":[19],"are":[20,226],"still":[21,227],"urgent":[22],"problems":[23],"to":[24,61,143,152,193,292],"be":[25,42,293,368],"solved.":[26],"Anlotinib":[27],"was":[28,60,147,171,176,263,269,299],"an":[29],"effective":[30],"second-line":[31],"monotherapy":[32],"ESCC":[34,56,80,357],"in":[35,55,97,241,353,370],"China":[36],"the":[38,63,129,134,274,296,308,315],"combination":[39],"might":[41],"a":[43,196],"promising":[44],"strategy.":[45],"Nab-paclitaxel":[46],"plus":[47],"cisplatin":[48,70,115,352],"as":[49,74],"first-line":[50],"exhibited":[52,358],"moderate":[53],"efficacy":[54,64,360],"patients.":[57],"This":[58],"study":[59],"investigate":[62],"safety":[66,304],"of":[67,131,141,198,214,356],"nab-paclitaxel":[68,110,350],"combined":[71,108,348],"anlotinib":[73,103,347],"neoadjuvant":[75,124,132,215,229,354],"treatment":[76,221,355],"ESCC.":[78],"Methods:":[79],"preoperative":[83],"clinical":[84],"stage":[85],"II-III":[86],"all":[88],"who":[90,232],"can":[91],"receive":[92],"radical":[93,137],"surgery":[94,138,209,235],"were":[95,180,202,239,250,290,319,340],"recruited":[96],"this":[98,242],"study.":[99],"Eligible":[100],"received":[102,234],"(12mg,":[104],"po,":[105],"d1\u030314,":[106],"q3w)":[107,113,119],"(175mg/m2,":[111],"iv,":[112,117],"(20mg/m2,":[116],"d1\u03033,":[118],"2":[121,163,212,258],"cycles":[122,213],"during":[123],"therapy.":[125,230],"4":[126,251,287],"weeks":[127,164],"after":[128,139,210],"end":[130],"therapy,":[133,216],"underwent":[136,208,282],"exclusion":[140],"contraindications":[142],"surgery.":[144,166],"Tumor":[145],"response":[146,247],"assessed":[148],"by":[149],"investigator":[150],"according":[151],"RECIST":[153],"version":[154],"1.1":[155],"using":[156],"CT":[157],"scans":[158],"at":[159],"baseline":[160],"within":[162],"before":[165],"The":[167,173,303,365],"calculated":[168],"sample":[169],"size":[170],"62.":[172],"primary":[174],"endpoint":[175],"ORR,":[177],"secondary":[178],"endpoints":[179],"R0":[181,283],"resection":[182],"rate,":[183],"DFS,":[184],"OS,":[185],"DCR":[186,268],"safety.":[188],"Results:":[189],"From":[190],"Apr":[191],"2021":[192],"Dec":[194],"2021,":[195],"total":[197],"26":[199],"eligible":[200],"enrolled.":[203],"Among":[204,285],"them,":[205,286],"17":[206,278],"completing":[211],"3":[217],"chose":[219],"other":[220],"options,":[222],"6":[224],"receiving":[228],"had":[233,281],"(n":[236],"=":[237],"17)":[238],"included":[240,373],"analysis.":[243],"In":[244],"best":[245],"overall":[246],"assessment,":[248],"there":[249],"CR":[252],"(23.5%),":[253],"11":[254],"PR":[255],"(64.7%)":[256],"SD":[259],"(11.8%).":[260],"Consequently,":[261],"ORR":[262],"88.2%":[264],"(95%CI:":[265,271],"63.6\u030398.5%)":[266],"100.0%":[270],"80.5\u0303100.0%).":[272],"At":[273],"data":[275],"cut-off":[276],"date,":[277],"(100.0%)":[280],"resection.":[284],"(23.5%)":[289],"confirmed":[291],"pCR.":[294],"And":[295],"median":[297],"DFS":[298],"not":[300],"yet":[301],"available.":[302],"profile":[305],"suggested":[306,345],"that":[307,346],"most":[309],"common":[310],"treatment-emergent":[311],"adverse":[312,338,363],"events":[313,339],"incidence":[316],">":[317],"10%":[318],"gastrointestinal":[320],"reactions":[321],"(65.4%),":[322],"hypokalemia":[323],"(19.2%),":[324],"nausea":[325],"(15.4%),":[326,329],"liver":[327],"damage":[328],"myelosuppression":[330],"(11.5%)":[331],"vomit":[333],"(11.5%).":[334],"No":[335],"grade":[336],"\u22653":[337],"noted.":[341],"Conclusions:":[342],"Preliminary":[343],"results":[344],"encouraging":[359],"manageable":[362],"events.":[364],"conclusion":[366],"should":[367],"validated":[369],"more":[371],"subsequently.":[374]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2022-07-21T00:00:00"}